Literature DB >> 25301987

Comparison of Iron Oxide Nanoparticle and Waterbath Hyperthermia Cytotoxicity.

Ja Ogden1, Ja Tate1, Rr Strawbridge2, R Ivkov3, Pj Hoopes4.   

Abstract

The development of medical grade iron oxide nanoparticles (IONP) has renewed interest in hyperthermia cancer therapy. Because of their modifiable size and heating capabilities under an AC magnetic field (alternating magnetic field, AMF), IONPs have the potential to damage or kill cells in a manner more therapeutically efficient than previous hyperthermia techniques. The use of IONPs in hyperthermia cancer therapy has prompted numerous questions regarding the cytotoxic mechanism associated with IONP heat therapy and if such mechanism is different (more or less effective) with respect to conventional hyperthermia techniques.

Entities:  

Keywords:  AMF; Iron oxide; MCF-7; TEM; alternating magnetic field; efficacy; hyperthermia; nanoparticle; transmission electron microscopy

Year:  2009        PMID： 25301987      PMCID： PMC4188350          DOI： 10.1117/12.809818

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN： 0277-786X


  8 in total

1.  Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy.

Authors:  Sally J DeNardo; Gerald L DeNardo; Laird A Miers; Arutselvan Natarajan; Alan R Foreman; Cordula Gruettner; Grete N Adamson; Robert Ivkov
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

Review 2.  Hyperthermia and hypoxia: new developments in anticancer chemotherapy.

Authors:  N Zaffaroni; G Fiorentini; U De Giorgi
Journal:  Eur J Surg Oncol       Date:  2001-06       Impact factor: 4.424

3.  Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice.

Authors:  Sally J DeNardo; Gerald L DeNardo; Arutselvan Natarajan; Laird A Miers; Allan R Foreman; Cordula Gruettner; Grete N Adamson; Robert Ivkov
Journal:  J Nucl Med       Date:  2007-03       Impact factor: 10.057

Review 4.  Magnetically mediated hyperthermia: current status and future directions.

Authors:  P Moroz; S K Jones; B N Gray
Journal:  Int J Hyperthermia       Date:  2002 Jul-Aug       Impact factor: 3.914

Review 5.  The cellular and molecular basis of hyperthermia.

Authors:  Bert Hildebrandt; Peter Wust; Olaf Ahlers; Annette Dieing; Geetha Sreenivasa; Thoralf Kerner; Roland Felix; Hanno Riess
Journal:  Crit Rev Oncol Hematol       Date:  2002-07       Impact factor: 6.312

6.  Tumor response to arterial embolization hyperthermia and direct injection hyperthermia in a rabbit liver tumor model.

Authors:  Paul Moroz; Stephen K Jones; Bruce N Gray
Journal:  J Surg Oncol       Date:  2002-07       Impact factor: 3.454

Review 7.  Heating the patient: a promising approach?

Authors:  J van der Zee
Journal:  Ann Oncol       Date:  2002-08       Impact factor: 32.976

8.  Intratumoral Iron Oxide Nanoparticle Hyperthermia and Radiation Cancer Treatment.

Authors:  Pj Hoopes; Rr Strawbridge; Uj Gibson; Q Zeng; Ze Pierce; M Savellano; Ja Tate; Ja Ogden; I Baker; R Ivkov; Ar Foreman
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2007-02-13
  8 in total
  2 in total

1.  Cell damage produced by magnetic fluid hyperthermia on microglial BV2 cells.

Authors:  M Pilar Calatayud; Elisa Soler; Teobaldo E Torres; Enrique Campos-Gonzalez; Concepción Junquera; M Ricardo Ibarra; Gerardo F Goya
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

2.  Local Overheating of Biotissue Labeled With Upconversion Nanoparticles Under Yb3+ Resonance Excitation.

Authors:  Ivan V Krylov; Roman A Akasov; Vasilina V Rocheva; Natalya V Sholina; Dmitry A Khochenkov; Andrey V Nechaev; Nataliya V Melnikova; Alexey A Dmitriev; Andrey V Ivanov; Alla N Generalova; Evgeny V Khaydukov
Journal:  Front Chem       Date:  2020-05-08       Impact factor: 5.221
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.